nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—MTOR—leg—osteoarthritis	0.0378	0.284	CbGeAlD
Sirolimus—MTOR—forelimb—osteoarthritis	0.0375	0.282	CbGeAlD
Sirolimus—MTOR—hindlimb—osteoarthritis	0.0338	0.253	CbGeAlD
Sirolimus—FGF2—tendon—osteoarthritis	0.00896	0.0672	CbGeAlD
Sirolimus—MTOR—tendon—osteoarthritis	0.00568	0.0427	CbGeAlD
Sirolimus—FKBP1A—tendon—osteoarthritis	0.00511	0.0384	CbGeAlD
Sirolimus—SLC47A1—tendon—osteoarthritis	0.00439	0.033	CbGeAlD
Sirolimus—EIF4E—Immune System—CAMK2B—osteoarthritis	0.00137	0.00158	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CTSK—osteoarthritis	0.00137	0.00158	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00134	0.00155	CbGpPWpGaD
Sirolimus—MTOR—Cardiac Hypertrophic Response—TNF—osteoarthritis	0.00134	0.00154	CbGpPWpGaD
Sirolimus—MTOR—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.00133	0.00154	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CTSK—osteoarthritis	0.0013	0.0015	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.0013	0.0015	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—TNF—osteoarthritis	0.00129	0.00149	CbGpPWpGaD
Sirolimus—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.00128	0.00148	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	0.00126	0.00145	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CTSK—osteoarthritis	0.00125	0.00144	CbGpPWpGaD
Sirolimus—MTOR—CXCR4-mediated signaling events—MMP9—osteoarthritis	0.00124	0.00143	CbGpPWpGaD
Sirolimus—MTOR—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.00123	0.00142	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB4—ESR1—osteoarthritis	0.00122	0.00141	CbGpPWpGaD
Sirolimus—MTOR—TSLP Signaling Pathway—IL6—osteoarthritis	0.00122	0.00141	CbGpPWpGaD
Sirolimus—FGF2—Disease—IHH—osteoarthritis	0.00122	0.00141	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—IL1B—osteoarthritis	0.00122	0.0014	CbGpPWpGaD
Sirolimus—MTOR—Regulation of Telomerase—TGFB1—osteoarthritis	0.00121	0.00139	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFBI—osteoarthritis	0.0012	0.00139	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00119	0.00137	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP1—osteoarthritis	0.00115	0.00132	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—CXCL8—osteoarthritis	0.00115	0.00132	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL1A—osteoarthritis	0.00114	0.00131	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—COL9A2—osteoarthritis	0.00113	0.0013	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MCF2L—osteoarthritis	0.00113	0.0013	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IHH—osteoarthritis	0.00113	0.0013	CbGpPWpGaD
Sirolimus—FGF2—Signaling by SCF-KIT—MMP9—osteoarthritis	0.0011	0.00127	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—IL1B—osteoarthritis	0.0011	0.00127	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—COL9A1—osteoarthritis	0.0011	0.00126	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—HSPA5—osteoarthritis	0.00109	0.00125	CbGpPWpGaD
Sirolimus—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	0.00108	0.00124	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL1RN—osteoarthritis	0.00106	0.00122	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—FN1—osteoarthritis	0.00105	0.00121	CbGpPWpGaD
Sirolimus—FKBP1A—Spinal Cord Injury—IL6—osteoarthritis	0.00104	0.0012	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—GSTO1—osteoarthritis	0.00104	0.0012	CbGpPWpGaD
Sirolimus—FGF2—IRS-mediated signalling—IL6—osteoarthritis	0.00103	0.00118	CbGpPWpGaD
Sirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.00102	0.00118	CbGpPWpGaD
Sirolimus—MTOR—Disease—FMOD—osteoarthritis	0.00102	0.00117	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—IL1A—osteoarthritis	0.00101	0.00116	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—BGN—osteoarthritis	0.001	0.00116	CbGpPWpGaD
Sirolimus—FGF2—IRS-related events—IL6—osteoarthritis	0.000998	0.00115	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—HSPA5—osteoarthritis	0.000996	0.00115	CbGpPWpGaD
Sirolimus—FGF2—IRS-related events triggered by IGF1R—IL6—osteoarthritis	0.000989	0.00114	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000986	0.00114	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CTSK—osteoarthritis	0.000967	0.00112	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—MMP1—osteoarthritis	0.000965	0.00111	CbGpPWpGaD
Sirolimus—FGF2—Insulin receptor signalling cascade—IL6—osteoarthritis	0.000964	0.00111	CbGpPWpGaD
Sirolimus—FGF2—IGF1R signaling cascade—IL6—osteoarthritis	0.000964	0.00111	CbGpPWpGaD
Sirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.000953	0.0011	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000941	0.00109	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—LEP—osteoarthritis	0.000934	0.00108	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CTSK—osteoarthritis	0.000929	0.00107	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFBI—osteoarthritis	0.00091	0.00105	CbGpPWpGaD
Sirolimus—MTOR—Disease—IHH—osteoarthritis	0.000906	0.00104	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP2—osteoarthritis	0.000888	0.00102	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000878	0.00101	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MCF2L—osteoarthritis	0.000854	0.000986	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IHH—osteoarthritis	0.000854	0.000986	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—osteoarthritis	0.000854	0.000985	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—COL9A2—osteoarthritis	0.000828	0.000955	CbGpPWpGaD
Sirolimus—MTOR—Signaling by SCF-KIT—MMP9—osteoarthritis	0.000818	0.000944	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—COL9A1—osteoarthritis	0.000803	0.000927	CbGpPWpGaD
Sirolimus—FGF2—Signaling by Insulin receptor—IL6—osteoarthritis	0.0008	0.000924	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—SMAD3—osteoarthritis	0.000787	0.000908	CbGpPWpGaD
Sirolimus—FGF2—Disease—GSTO1—osteoarthritis	0.000786	0.000907	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—IGF1—osteoarthritis	0.000772	0.00089	CbGpPWpGaD
Sirolimus—MTOR—IRS-mediated signalling—IL6—osteoarthritis	0.000762	0.000879	CbGpPWpGaD
Sirolimus—FGF2—Disease—BGN—osteoarthritis	0.000762	0.000879	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL1A—osteoarthritis	0.000761	0.000878	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CAMK2B—osteoarthritis	0.000759	0.000876	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CTSK—osteoarthritis	0.000759	0.000876	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.000758	0.000874	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—BMP2—osteoarthritis	0.000751	0.000866	CbGpPWpGaD
Sirolimus—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.000748	0.000862	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—MMP2—osteoarthritis	0.000747	0.000862	CbGpPWpGaD
Sirolimus—MTOR—IRS-related events—IL6—osteoarthritis	0.000741	0.000855	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—HSPA5—osteoarthritis	0.000739	0.000853	CbGpPWpGaD
Sirolimus—MTOR—IRS-related events triggered by IGF1R—IL6—osteoarthritis	0.000734	0.000847	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—FMOD—osteoarthritis	0.000732	0.000844	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—SMAD3—osteoarthritis	0.000724	0.000836	CbGpPWpGaD
Sirolimus—MTOR—Insulin receptor signalling cascade—IL6—osteoarthritis	0.000715	0.000825	CbGpPWpGaD
Sirolimus—MTOR—IGF1R signaling cascade—IL6—osteoarthritis	0.000715	0.000825	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000713	0.000822	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—IL6—osteoarthritis	0.000712	0.000821	CbGpPWpGaD
Sirolimus—FGF2—Signaling by SCF-KIT—IL6—osteoarthritis	0.000685	0.00079	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFBI—osteoarthritis	0.000675	0.000779	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—LEP—osteoarthritis	0.000673	0.000776	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—FMOD—osteoarthritis	0.000672	0.000775	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—MMP9—osteoarthritis	0.000668	0.00077	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000666	0.000768	CbGpPWpGaD
Sirolimus—FGF2—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000655	0.000756	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB4—IL6—osteoarthritis	0.000645	0.000744	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—osteoarthritis	0.000643	0.000742	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CRP—osteoarthritis	0.000636	0.000734	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MCF2L—osteoarthritis	0.000634	0.000732	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IHH—osteoarthritis	0.000634	0.000732	CbGpPWpGaD
Sirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—osteoarthritis	0.000634	0.000731	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—COL9A2—osteoarthritis	0.000627	0.000724	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—CXCL8—osteoarthritis	0.000621	0.000716	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	0.000619	0.000714	CbGpPWpGaD
Sirolimus—FGF2—Downstream signal transduction—IL6—osteoarthritis	0.000616	0.00071	CbGpPWpGaD
Sirolimus—FGF2—Signaling by FGFR—IL6—osteoarthritis	0.000613	0.000707	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB2—IL6—osteoarthritis	0.00061	0.000704	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—COL9A1—osteoarthritis	0.000609	0.000702	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—CRP—osteoarthritis	0.000607	0.000701	CbGpPWpGaD
Sirolimus—FGF2—DAP12 signaling—IL6—osteoarthritis	0.000607	0.0007	CbGpPWpGaD
Sirolimus—FGF2—Immune System—HSPA5—osteoarthritis	0.000604	0.000697	CbGpPWpGaD
Sirolimus—MTOR—Signaling by VEGF—IL6—osteoarthritis	0.000598	0.00069	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGES—osteoarthritis	0.000596	0.000688	CbGpPWpGaD
Sirolimus—MTOR—Signaling by Insulin receptor—IL6—osteoarthritis	0.000594	0.000685	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—IL1B—osteoarthritis	0.000594	0.000685	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—ESR1—osteoarthritis	0.000591	0.000682	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1RN—osteoarthritis	0.000588	0.000678	CbGpPWpGaD
Sirolimus—MTOR—Disease—GSTO1—osteoarthritis	0.000584	0.000673	CbGpPWpGaD
Sirolimus—FGF2—Signaling by FGFR in disease—IL6—osteoarthritis	0.000571	0.000659	CbGpPWpGaD
Sirolimus—FGF2—DAP12 interactions—IL6—osteoarthritis	0.000571	0.000659	CbGpPWpGaD
Sirolimus—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000571	0.000659	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR—IL6—osteoarthritis	0.000566	0.000653	CbGpPWpGaD
Sirolimus—MTOR—Disease—BGN—osteoarthritis	0.000565	0.000652	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CTSK—osteoarthritis	0.000563	0.00065	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CAMK2B—osteoarthritis	0.000563	0.00065	CbGpPWpGaD
Sirolimus—FGF2—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000561	0.000647	CbGpPWpGaD
Sirolimus—FGF2—Signaling by PDGF—IL6—osteoarthritis	0.000558	0.000644	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—BMP2—osteoarthritis	0.000551	0.000635	CbGpPWpGaD
Sirolimus—FGF2—Extracellular matrix organization—TGFB1—osteoarthritis	0.00055	0.000635	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—CXCL8—osteoarthritis	0.000548	0.000632	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGES—osteoarthritis	0.000547	0.000632	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP2—osteoarthritis	0.000538	0.000621	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP3—osteoarthritis	0.00052	0.0006	CbGpPWpGaD
Sirolimus—MTOR—Signaling by SCF-KIT—IL6—osteoarthritis	0.000508	0.000586	CbGpPWpGaD
Sirolimus—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000506	0.000583	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—SMAD3—osteoarthritis	0.000493	0.000569	CbGpPWpGaD
Sirolimus—MTOR—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000486	0.000561	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—FMOD—osteoarthritis	0.000485	0.00056	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB4—IL6—osteoarthritis	0.000479	0.000552	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—SMAD3—osteoarthritis	0.000471	0.000543	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—COL9A2—osteoarthritis	0.000465	0.000537	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	0.000461	0.000532	CbGpPWpGaD
Sirolimus—MTOR—Downstream signal transduction—IL6—osteoarthritis	0.000457	0.000527	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR—IL6—osteoarthritis	0.000455	0.000525	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB2—IL6—osteoarthritis	0.000453	0.000522	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—COL9A1—osteoarthritis	0.000452	0.000521	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—CRP—osteoarthritis	0.000451	0.00052	CbGpPWpGaD
Sirolimus—MTOR—DAP12 signaling—IL6—osteoarthritis	0.00045	0.00052	CbGpPWpGaD
Sirolimus—MTOR—Immune System—HSPA5—osteoarthritis	0.000448	0.000517	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000439	0.000506	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1RN—osteoarthritis	0.000436	0.000503	CbGpPWpGaD
Sirolimus—ABCB1—Allograft Rejection—TNF—osteoarthritis	0.000431	0.000497	CbGpPWpGaD
Sirolimus—MTOR—Signaling by FGFR in disease—IL6—osteoarthritis	0.000424	0.000489	CbGpPWpGaD
Sirolimus—MTOR—DAP12 interactions—IL6—osteoarthritis	0.000424	0.000489	CbGpPWpGaD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000424	0.000489	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1A—osteoarthritis	0.000423	0.000488	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—GSTO1—osteoarthritis	0.00042	0.000485	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR—IL6—osteoarthritis	0.00042	0.000484	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—BMP2—osteoarthritis	0.000417	0.000481	CbGpPWpGaD
Sirolimus—MTOR—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000416	0.00048	CbGpPWpGaD
Sirolimus—MTOR—Signaling by PDGF—IL6—osteoarthritis	0.000414	0.000478	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—BGN—osteoarthritis	0.000407	0.00047	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—MMP9—osteoarthritis	0.000404	0.000467	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—LEP—osteoarthritis	0.000403	0.000464	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL1B—osteoarthritis	0.000397	0.000458	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGES—osteoarthritis	0.000396	0.000457	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—IL6—osteoarthritis	0.000389	0.000449	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—GSTO1—osteoarthritis	0.000386	0.000445	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—ESR1—osteoarthritis	0.000384	0.000443	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP3—osteoarthritis	0.000382	0.00044	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00038	0.000438	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—FN1—osteoarthritis	0.00038	0.000438	CbGpPWpGaD
Sirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000375	0.000433	CbGpPWpGaD
Sirolimus—FGF2—Disease—SMAD3—osteoarthritis	0.000374	0.000431	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—BGN—osteoarthritis	0.000374	0.000431	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—FMOD—osteoarthritis	0.000366	0.000423	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CRP—osteoarthritis	0.000354	0.000408	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SMAD3—osteoarthritis	0.000345	0.000399	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TGFB1—osteoarthritis	0.000333	0.000385	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IGF1—osteoarthritis	0.000333	0.000384	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000315	0.000363	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1A—osteoarthritis	0.000314	0.000362	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—TNF—osteoarthritis	0.000311	0.000359	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—BMP2—osteoarthritis	0.00031	0.000357	CbGpPWpGaD
Sirolimus—MTOR—Cellular responses to stress—IL6—osteoarthritis	0.000308	0.000355	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGES—osteoarthritis	0.000299	0.000345	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—LEP—osteoarthritis	0.000295	0.000341	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP3—osteoarthritis	0.000289	0.000334	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PTGS2—osteoarthritis	0.000289	0.000333	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—IL6—osteoarthritis	0.000289	0.000333	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—ESR1—osteoarthritis	0.000282	0.000325	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—GSTO1—osteoarthritis	0.000279	0.000322	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—FN1—osteoarthritis	0.000278	0.000321	CbGpPWpGaD
Sirolimus—MTOR—Disease—SMAD3—osteoarthritis	0.000277	0.00032	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—BGN—osteoarthritis	0.00027	0.000312	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CXCL8—osteoarthritis	0.000267	0.000309	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000263	0.000303	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CRP—osteoarthritis	0.000262	0.000303	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SMAD3—osteoarthritis	0.000262	0.000302	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—IL6—osteoarthritis	0.000251	0.00029	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IGF1—osteoarthritis	0.000244	0.000281	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—MMP9—osteoarthritis	0.000242	0.000279	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—IL6—osteoarthritis	0.000232	0.000268	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000228	0.000263	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000226	0.00026	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—LEP—osteoarthritis	0.000224	0.000258	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—IL6—osteoarthritis	0.000222	0.000256	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL1B—osteoarthritis	0.000221	0.000255	CbGpPWpGaD
Sirolimus—FGF2—Disease—PTGS2—osteoarthritis	0.000219	0.000253	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP3—osteoarthritis	0.000215	0.000248	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—ESR1—osteoarthritis	0.000214	0.000246	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000213	0.000245	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—FN1—osteoarthritis	0.000211	0.000243	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—GSTO1—osteoarthritis	0.00021	0.000243	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—TGFB1—osteoarthritis	0.000209	0.000241	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—BGN—osteoarthritis	0.000204	0.000235	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TGFB1—osteoarthritis	0.000199	0.00023	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CXCL8—osteoarthritis	0.000196	0.000226	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SMAD3—osteoarthritis	0.000194	0.000224	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IGF1—osteoarthritis	0.000185	0.000213	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGES—osteoarthritis	0.000184	0.000212	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—MMP9—osteoarthritis	0.000177	0.000205	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—LEP—osteoarthritis	0.000166	0.000192	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—IL6—osteoarthritis	0.000165	0.00019	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL1B—osteoarthritis	0.000164	0.000189	CbGpPWpGaD
Sirolimus—MTOR—Disease—PTGS2—osteoarthritis	0.000162	0.000187	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—ESR1—osteoarthritis	0.000159	0.000183	CbGpPWpGaD
Sirolimus—FGF2—Disease—TGFB1—osteoarthritis	0.000158	0.000183	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—IL6—osteoarthritis	0.000157	0.000182	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—FN1—osteoarthritis	0.000157	0.000181	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IL6—osteoarthritis	0.00015	0.000173	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CXCL8—osteoarthritis	0.000149	0.000172	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TGFB1—osteoarthritis	0.000146	0.000169	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IGF1—osteoarthritis	0.000137	0.000158	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—MMP9—osteoarthritis	0.000134	0.000155	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.00013	0.00015	CbGpPWpGaD
Sirolimus—FGF2—Immune System—IL6—osteoarthritis	0.000129	0.000149	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—BGN—osteoarthritis	0.000126	0.000145	CbGpPWpGaD
Sirolimus—FGF2—Disease—IL6—osteoarthritis	0.000119	0.000138	CbGpPWpGaD
Sirolimus—MTOR—Disease—TGFB1—osteoarthritis	0.000117	0.000136	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PTGS2—osteoarthritis	0.000117	0.000135	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TGFB1—osteoarthritis	0.000111	0.000128	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CXCL8—osteoarthritis	0.00011	0.000127	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IL6—osteoarthritis	0.00011	0.000127	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PTGS2—osteoarthritis	0.000107	0.000124	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—MMP9—osteoarthritis	9.98e-05	0.000115	CbGpPWpGaD
Sirolimus—MTOR—Immune System—IL6—osteoarthritis	9.59e-05	0.000111	CbGpPWpGaD
Sirolimus—MTOR—Disease—IL6—osteoarthritis	8.85e-05	0.000102	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IL6—osteoarthritis	8.35e-05	9.64e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TGFB1—osteoarthritis	8.23e-05	9.49e-05	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PTGS2—osteoarthritis	7.76e-05	8.96e-05	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IL6—osteoarthritis	6.2e-05	7.15e-05	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PTGS2—osteoarthritis	5.86e-05	6.76e-05	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PTGS2—osteoarthritis	3.61e-05	4.16e-05	CbGpPWpGaD
